Series B funding round for Enveda Biosciences raising $55M in December 2022
Series B funding round for Enveda Biosciences raising $55M in December 2022
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Henry Kravis | |
| Angel | rajiv chegu | |
| Angel | Jonathan Milner | |
| Angel | Chris Gibson |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$592M
Top Valuation
-
Enveda Biosciences raised $55M in a Series B round.
The round was announced on 12/01/22.
The round was led by Dimension Capital.